Cancer research often involves the comparison of gene expression profiles between tumor and normal tissues or between different subtypes of cancer. DESeq2 provides a robust framework for identifying genes that are differentially expressed, which can help in understanding the molecular mechanisms underlying cancer, identifying potential biomarkers, and discovering new therapeutic targets.
